PF-Atlas › Clinical Trials › NCT04019080

Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden

Anti-fibrostic drugs · Not specified

Registry ID
NCT04019080
Phase
Not specified
Status
Unknown
Drug / intervention
Anti-fibrostic drugs
Sponsor
Karolinska University Hospital
Start
2019-01-01
Enrollment
400
Locations
1

About this trial

The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives are to determine the clinical profile, determinants of treatment adherence, long-term safety and to describe the patient journey from the first sign of disease to end of treatment.

View NCT04019080 on ClinicalTrials.gov →

Explore related

All Anti-fibrostic drugs trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT04019080 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.